Purchase Order HT940624P0142
Award Date
10/1/24
Potential Completion Date
9/30/25
Potential Value
$50K
Federal Agency
Defense Health Agency
Awardee
Biomerieux Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
W065 - Lease Or Rental Of Equipment- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Jacksonville, FL 32214, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Health Agency (DHA) awarded a firm-fixed-price delivery order contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of a microbiology analyzer and consumables. The $87,980.77 contract has an ultimate completion date of December 16, 2022. Biomerieux Inc., through its Biomerieux, Inc. division, is the sole awardee and is not subject to any set-aside designations. The company is known for its proprietary diagnostic platforms, such as VITEK,...
This $212,471.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of Biomerieux's proprietary microbiology analyzer equipment, reagents, and technical support services to enable infectious disease testing and identification. This award is associated with Biomerieux's existing indefinite delivery contracts and blanket purchase agreements...
The U.S. Defense Health Agency (DHA) awarded a $104,946.66 firm-fixed-price contract to Biomerieux Inc., a global leader in in vitro diagnostics, to provide microbiology analyzers and reagents to support the Keesler Medical Center. The contract, which does not involve any set-aside designations, will run from October 1, 2023, to March 31, 2025, with the potential for two 6-month option periods. Biomerieux Inc., through its Biomerieux, Inc. division, will deliver its proprietary VITEK and BioFire...
The U.S. Defense Health Agency (DHA) awarded a $164,607.03 firm-fixed-price purchase order contract to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic products and equipment. The contract is for the provision of reagents and supplies, with a completion date of September 30, 2023. Biomerieux Inc. is a leader in microbiology testing solutions for medical and industrial applications, providing products and services that support infectious disease testing and food...
This is a federal contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of reagents, materials, and test supplies. The $15,370.43 firm-fixed-price contract has an ultimate completion date of October 15, 2024. Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the Departments of Veterans Affairs,...
This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $11,258.96, is for the provision of Biomerieux supplies and services, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated reagents and test kits. Biomerieux, through its Biomerieux, Inc. division, has been a long-standing supplier of clinical diagnostic equipment and consumables to various...
This is a firm-fixed-price purchase order awarded to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BioMerieux BACT/ALERT 3D and 3D automated blood culture system supplies and services. The $11,058.64 contract was awarded by the Defense Health Agency, a defense agency, with an ultimate completion date of October 1, 2024. The award does not involve any set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, is the prime contractor for this...
The Defense Health Agency awarded Biomerieux Inc. a $150,032.43 firm fixed price delivery order for a microbiology analyzer with no set-aside designation. Under this contract, Biomerieux will provide the Defense Health Agency with a microbiology analyzer to support the agency's medical research and healthcare programs. The place of performance is in Eno Valley, North Carolina, with no subcontractors mentioned. This delivery order was awarded on October 27, 2020 and is to be completed by November...
Biomerieux Inc. was awarded a $133,072.34 firm fixed price delivery order against an unspecified contract vehicle to provide a microbiology analyzer to the Defense Health Agency. The delivery order has no set-aside designation and calls for the analyzer to be delivered to a location in Eno Valley, North Carolina by August 17, 2022. As the contracting agency, the Defense Health Agency supports the medical readiness of military forces and oversees health care delivery systems and programs within...
The Defense Health Agency (DHA) awarded a firm-fixed-price purchase order contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the supply of BAC-T ALERT FA/FN PLUS diagnostic products. The contract, valued at $46,880.00, will support infectious disease testing and pathogen detection requirements at the Eglin Air Force Base in Florida. The contract has an ultimate completion date of June 1, 2025. Biomerieux Inc. holds several significant federal Indefinite Delivery...